774
M. Matsunami et al.
LETTER
C13H16O3: C, 70.89; H, 7.32. Found: C, 70.63; H, 7.09.
cm–1. MS (EI): m/z = 278 [M+]. Anal. Calcd for C18H14O3: C,
77.68; H, 5.07. Found: C, 77.95; H, 5.20.
Benzyl 4-Oxoheptanoate (8b).
Benzyl 2-(1-Oxopropyl)-4-oxohexanoate (7a).
1H NMR (400 MHz, CDCl3): d = 0.91 (t, J = 7.4 Hz, 3 H),
1.61 (sext, J = 7.4 Hz, 2 H), 2.42 (t, J = 7.4 Hz, 2 H), 2.64 (t,
J = 6.3 Hz, 2 H), 2.72 (t, J = 6.3 Hz, 2 H), 5.14 (s, 2 H),
7.30–7.38 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 13.63, 17.19, 27.90, 36.93, 44.61, 66.39, 128.12, 128.16,
128.48, 135.80, 172.60, 208.86 ppm. IR (neat): 3034, 2962,
2939, 1735, 1715, 1648, 1608, 1498 1456, 1383 cm–1. MS
(EI): m/z = 234 [M+]. Anal. Calcd for C14H18O3: C, 71.77; H,
7.74. Found: C, 72.01, H, 8.01.
1H NMR (400 MHz, CDCl3): d = 1.02 (t, J = 7.3 Hz, 3 H),
1.03 (t, J = 7.3 Hz, 3 H), 2.46 (q, J = 7.3 Hz, 2 H), 2.59–2.74
(m, 2 H), 2.93 (dd, J = 5.6, 18.3 Hz, 1 H), 3.15 (dd, J = 8.4,
18.3 Hz, 1 H), 4.07 (dd, J = 5.6, 8.4 Hz, 1 H), 5.12 (d,
J = 12.5 Hz, 1 H), 5.16 (d, J = 12.5 Hz, 1 H), 7.30–7.38 (m,
5 H) ppm. 13C NMR (100 MHz, CDCl3): d = 7.56, 7.63,
35.63, 36.24, 40.38, 52.73, 67.25, 128.04, 128.34, 128.48,
134.98, 168.65, 204.73, 208, 25 ppm. IR (neat): 3034, 2979,
2940, 2882, 1743, 1715, 1655, 1608, 1498, 1457, 1377 cm–1.
MS (EI): m/z = 276 [M+]. Anal. Calcd for C28H28N8O10 [di-
(2,4-dinitrophenylhydrazone)]: C, 52.83; H, 4.43; N, 17.60.
Found: C, 52.78; H, 4.69; N, 17.31.
Benzyl 5-Methyl-4-oxohexanoate (8c).
1H NMR (400 MHz, CDCl3): d = 1.11 (d, J = 6.8 Hz, 6 H),
2.59–2.65 (m, 3 H), 2.78 (t, J = 6.5 Hz, 2 H), 5.11 (s, 2 H),
7.31–7.36 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 18.15, 27.94, 34.65, 40.72, 66.36, 128.13 (× 2), 128.47,
135.82, 172.65, 212.52 ppm. IR (neat): 3034, 2971, 2934,
2876, 1735, 1712, 1608, 1498, 1456, 1384 cm–1. MS (EI):
m/z = 234 [M+]. Anal. Calcd for C14H18O3: C, 71.77; H, 7.74.
Found: C, 71.84, H, 7.95.
Benzyl 2-(1-Oxobutyl)-4-oxoheptanoate (7b).
1H NMR (400 MHz, CDCl3): d = 0.84 (t, J = 7.4 Hz, 3 H),
0.89 (t, J = 7.4 Hz, 3 H), 1.57 (sext, J = 7.4 Hz, 4 H), 2.41 (t,
J = 7.4 Hz, 2 H), 2.54–2.67 (m, 2 H), 2.91 (dd, J = 5.8, 18.3
Hz, 1 H), 3.12 (dd, J = 8.3, 18.3 Hz, 1 H), 4.06 (dd, J = 5.8,
8.3 Hz, 1 H), 5.12 (d, J = 12.2 Hz, 1 H), 5.16 (d, J = 12.2 Hz,
1 H), 7.30–7.37 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 13.42, 13.61, 16.80, 17.18, 40.65, 44.38, 44.68, 53.03,
67.23, 128.14, 128.34, 128.46, 135.01, 168.63, 203.97,
207.76 ppm. IR (neat): 3036, 2966, 2936, 2877, 1742, 1713,
1648, 1609, 1498, 1456, 1407, 1377cm–1. MS (EI): m/z =
304 [M+]. Anal. Calcd for C18H24O4: C, 71.03; H, 7.95.
Found: C, 71.15; H, 8.11.
Benzyl 6-Methyl-4oxoheptanoate (8d).
1H NMR (400 MHz, CDCl3): d = 0.91 (d, J = 6.7 Hz, 6 H),
2.10–2.20 (m, 1 H), 2.32 (d, J = 6.7 Hz, 2 H), 2.63 (t, J = 6.2
Hz, 2 H), 2.71 (t, J = 6.2 Hz, 2 H), 5.11 (s, 2 H), 7.33–7.35
(m, 5 H) ppm. 13C NMR (100 MHz, CDCl3): d = 22.50,
24.62, 27.87, 37.51, 51.69, 66.39, 128.14, 128.17, 128.50,
135.82, 172.61, 208.57 ppm. IR (neat): 3034, 2972, 2957,
2935, 2872, 1735, 1718, 1606, 1497, 1466, 1385 cm–1. MS
(EI): m/z = 248 [M+]. Anal. Calcd for C15H20O3: C, 72.55; H,
8.12. Found: C, 72.56; H, 8.29.
Benzyl 2-(2-Methyl-1-oxopropyl)-5-methyl-4-oxo-
hexanoate (7c).
1H NMR (400 MHz, CDCl3): d = 1.03 (d, J = 6.8 Hz, 3 H),
1.09 (d, J = 7.1 Hz, 3 H), 1.10 (d, J = 7.1 Hz, 3 H), 1.13 (d,
J = 7.1 Hz, 3 H), 2.63 (sept, J = 6.8 Hz, 1 H), 2.83–2.98 (m,
2 H), 3.15 (dd, J = 8.2, 18.3 Hz, 1 H), 4.24 (dd, J = 5.6, 8.2
Hz, 1 H), 5.12 (d, J = 12.2 Hz, 1 H), 5.16 (d, J = 12.2 Hz, 1
H), 7.26–7.38 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 17.76, 18.12, 18.17, 18.66, 38.62, 40.68, 40.79, 51.39,
67.29, 128.17, 128.35, 128.48, 135.03, 168.89, 207.90,
211.25 ppm. IR (neat): 3035, 2972, 2935, 2875, 1743, 1713,
1648, 1609, 1498, 1456, 1384 cm–1. MS (EI): m/z = 304
[M+]. Anal. Calcd for C30H32N8O10 [di(2,4-dinitrophenyl-
hydrazone)]: C, 54.21; H, 4.85; N,16.86. Found: C, 53.94; H,
5.05; N, 16.68.
(8) (a) Bogdanovic, B.; Liao, S.; Mynott, R.; Schlichte, K.;
Westeppe, U. Chem. Ber. 1984, 117, 1378. (b) Bartmann,
E.; Bogdanovic, B.; Janke, N.; Liao, S.; Schlichte, K.;
Shliethoff, B.; Treber, J.; Westeppe, U.; Wilczok, U. Chem.
Ber. 1990, 123, 1517. (c) Bogdanovic, B.; Janke, N.;
Kinzelmann, H. G.; Seevogel, K.; Treber, J. Chem. Ber.
1990, 123, 1529.
(9) (a) Freeman, P. K.; Hutchinson, L. L. J. Org. Chem. 1983,
48, 879. (b) Bogdanovic, B. Acc. Chem. Res. 1988, 21, 261.
(10) Mg–anthracene·3THF complex can be available from
Sigma-Aldrich Co. Ltd.
(11) Treatment of anthracene(1) with isobutyryl chloride and
succinyl dichloride in the presence of 5 equiv of THF (based
on 1) in DMF under the similar conditions as mentioned
above, gave the corresponding adducts 2d and 5a in 56–59%
and 61–63% yields, respectively.
Benzyl 2-(3-Methyl-1-oxobutyl)-6-methyl-4-oxo-
heptanoate (7d).
1H NMR (400 MHz, CDCl3): d = 0.81 (d, J = 6.6 Hz, 3 H),
0.87 (d, J = 6.6 Hz, 3 H), 0.89 (d, J = 6.6 Hz, 3 H), 0.91 (d,
J = 6.6 Hz, 3 H), 2.07–2.17 (m, 2 H), 2.31 (d, J = 7.1 Hz, 2
H), 2.48 (d, J = 6.8 Hz, 2 H), 2.88 (dd, J = 5.8, 18.4 Hz, 1 H),
3.10 (dd, J = 8.3, 18.4 Hz, 1 H), 4.03 (dd, J = 5.8, 8.3 Hz, 1
H), 5.12 (d, J = 12.1 Hz, 1 H), 5.17 (d, J = 12.1 Hz, 1 H),
7.26–7.38 (m, 5 H) ppm. 13C NMR (100 MHz, CDCl3):
d = 22.18, 22.46, 22.50, 22.52, 23.92, 24.72, 41.16, 51.45,
51.61, 53.35, 67.29, 128.29, 128.41, 128.50, 134.99, 168.62,
203.49, 207.56 ppm. IR (neat): 3034, 2959, 2935, 2872,
1743, 1715, 1649, 1610, 1499, 1457, 1368 cm–1. MS (EI):
m/z = 332 [M+]. Anal. Calcd for C32H36N8O10 [di(2,4-dinitro-
phenylhydrazone)]: C, 55.49; H, 5.24; N,16.18. Found: C,
55.51; H, 5.14; N, 16.18.
(12) Typical Procedure for Electroreductive Double C-
Acylation of Anthracene Derivatives.
Into a 100-mL beaker-type undivided cell equipped with
platinum plates [20 × 30 × 0.5 mm, Nacalai Tesque (Kyoto,
Japan), 99%] as the cathode and a carbon bar as the anode
were introduced 60 mL of anhyd DMF as a solvent, n-
Et4NOTs (15 mmol) as a supporting electrolyte, acid
dichloride (25 mmol) and anthracene (5 mmol). The
electrolysis was carried out under constant current
conditions (current density: 7 mA/cm2) at –5 °C to 5 °C with
magnetic stirring until 8 F/mol of electricity was passed.
After the reaction, the reaction mixture was poured into sat.
NaHCO3 solution when acid dichloride was used as the
acylating agent. Organic materials were extracted with three
100 mL portions of Et2O. The combined ethereal solution
was washed with sat. NaCl solution and dried over anhyd
MgSO4. After removal of MgSO4 by filtration and
evaporation of the solvent, the isolation by column
chromatography gave diacylated compounds in low yields
(4%).
Benzyl 4-Oxohexanoate (8a).
1H NMR (400 MHz, CDCl3): d = 1.06 (t, J = 7.3 Hz, 3 H),
2.47 (q, J = 7.3 Hz, 2 H), 2.65 (t, J = 6.2 Hz, 2 H), 2.73 (t,
J = 6.2 Hz, 2 H), 5.14 (s, 2 H), 7.34–7.35 (m, 5 H) ppm. 13
NMR (100 MHz, CDCl3): d = 7.70, 27.97, 35.85, 36.52,
C
66.42, 128.14, 128.18, 128.50, 135.80, 172.65, 209.33 ppm.
IR (neat): 3034, 2977, 2939, 2882, 1735, 1719, 1648, 1608,
1498, 1379 cm–1. MS (EI): m/z = 220 [M+]. Anal. Calcd for
Synlett 2007, No. 5, 769–774 © Thieme Stuttgart · New York